Replimune (REPL) Receivables - Other (2018 - 2026)

Replimune (REPL) has 9 years of Receivables - Other data on file, last reported at $1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Other fell 56.24% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (down 56.24% YoY), and the FY2026 full-year result was $1.6 million, down 56.54% from the prior year.
• Receivables - Other slipped to $1.6 million in Q1 2026, from $3.0 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $4.9 million in Q2 2024 to a low of $1.6 million in Q1 2026.
• A 5-year average of $3.0 million and a median of $2.9 million in 2023 frame the typical range for Receivables - Other.
• Across the five-year window, Receivables - Other jumped 115.18% in 2023 and slumped 62.64% in 2025, its largest moves.
• Tracing REPL's Receivables - Other over 5 years: stood at $2.0 million in 2022, then soared by 115.18% to $4.3 million in 2023, then decreased by 28.61% to $3.1 million in 2024, then dropped by 3.62% to $3.0 million in 2025, then plunged by 45.21% to $1.6 million in 2026.
• Business Quant data shows REPL's Receivables - Other at $1.6 million in Q1 2026, $3.0 million in Q4 2025, and $1.8 million in Q3 2025.